6533b7d1fe1ef96bd125baf1
RESEARCH PRODUCT
Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development
Vadim Maratovich GadelshinVadim Maratovich GadelshinRoberto Formento CavaierRoberto Formento CavaierFerid HaddadReinhard HeinkeReinhard HeinkeReinhard HeinkeThierry StoraDominik StuderFelix WeberKlaus Wendtsubject
Medicine (General)theranosticsMaterials scienceCERN-MEDICISIon beam530 PhysicsGadolinium610 Medizinchemistry.chemical_elementTerbiumTERBIUMSURFACE PROPERTYIsotope separationlaw.inventionGADOLINIUMR5-920COMPARATIVE STUDYlawIonization610 Medical sciencesLASER RESONANCE IONIZATIONSAPPHIRE LASER [TI]ARTICLERADIOCHEMISTRYisotope separationTANTALUMOriginal ResearchTHERANOSTICSTi:Sapphire laserRISIKO MASS SEPARATORterbiumATOMIC SPECTROMETRYRadiochemistryTi:sapphire laserGeneral Medicine530 PhysikCharacterization (materials science)CONTROLLED STUDYchemistryRISIKO mass separatorION CURRENTMedicineISOTOPE SEPARATIONIONIZATIONAtomic ratiolaser resonance ionizationgadoliniumdescription
Terbium (Tb) is a promising element for the theranostic approach in nuclear medicine. The new CERN-MEDICIS facility aims for production of its medical radioisotopes to support related R&D projects in biomedicine. The use of laser resonance ionization is essential to provide radioisotopic yields of highest quantity and quality, specifically regarding purity. This paper presents the results of preparation and characterization of a suitable two-step laser resonance ionization process for Tb. By resonance excitation via an auto-ionizing level, the high ionization efficiency of 53% was achieved. To simulate realistic production conditions for Tb radioisotopes, the influence of a surplus of Gd atoms, which is a typical target material for Tb generation, was considered, showing the necessity of radiochemical purification procedures before mass separation. Nevertheless, a 10-fold enhancement of the Tb ion beam using laser resonance ionization was observed even with Gd:Tb atomic ratio of 100:1. © Copyright © 2021 Gadelshin, Formento Cavaier, Haddad, Heinke, Stora, Studer, Weber and Wendt. This research project has been supported by a Marie Skłodowska-Curie Innovative Training Network Fellowship of the European Commission’s Horizon 2020 Programme under contract number 642889 MEDICIS-PROMED; by the German Federal Ministry of Education and Research under the consecutive projects 05P12UMCIA and 05P15UMCIA. It has been also partially supported by Equipex ARRONAX-Plus (ANR-11-EQPX-0004), Labex IRON (ANR-11-LABX-18-01), ISITE NExT (ANR-16-IDEX-0007).
year | journal | country | edition | language |
---|---|---|---|---|
2021-10-01 |